Commonwealth Equity Services, LLC Meridian Bioscience Inc Transaction History

Commonwealth Equity Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$31.15 - $33.39 $206,399 - $221,242	6,626 New	6,626 $220,000
Q3 2021 Oct 29, 2021	SELL	$17.35 - $22.5 $162,413 - $210,622	-9,361 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$18.01 - $28.32 $168,591 - $265,103	9,361 New	9,361 $207,000
Q2 2018 Jul 31, 2018	SELL	$13.8 - $16.8 $176,805 - $215,241	-12,812 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$13.8 - $16.2 $3,491 - $4,098	253 Added 2.01%	12,812 $181,000
Q4 2017 Feb 12, 2018	BUY	$13.55 - $15.8 $170,174 - $198,432	12,559	12,559 $176,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.